The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort-Reference-Cited by-同舟云学术

The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort

Published:2017-12-01 Issue:4 Volume:31 Page:581-597
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ozkaya Neval,Rosenblum Marc K,Durham Benjamin H,Pichardo Janine D,Abdel-Wahab Omar,Hameed Meera R,Busam Klaus J,Travis William D,Diamond Eli L,Dogan Ahmet

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2017160.pdf

Reference14 articles.

1. Estrada-Veras JI, O’Brien KJ, Boyd LC et al. The clinical spectrum of Erdheim–Chester disease: an observational cohort study. Blood Adv 2017;1:357–366.

2. Mazor RD, Manevich-Mazor M, Shoenfeld Y . Erdheim–Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis 2013;8:137.

3. Cavalli G, Guglielmi B, Berti A et al. The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis 2013;72:1691–1695.

4. Arnaud L, Gorochov G, Charlotte F et al. Systemic perturbation of cytokine and chemokine networks in Erdheim–Chester disease: a single-center series of 37 patients. Blood 2011;117:2783–2790.

5. Haroche J, Charlotte F, Arnaud L et al. High prevalence of BRAF V600E mutations in Erdheim–Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012;120:2700–2703.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Manifestations of Systemic Diseases;Pulmonary Pathology;2025

2. Orbit;Ocular Pathology;2025

3. Erdheim‐Chester disease: A case report emphasizing diagnostic challenges and differential diagnosis;International Journal of Rheumatic Diseases;2024-09

4. Imaging in Erdheim-Chester Disease;RadioGraphics;2024-09-01

5. Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations;Clinical Immunology;2024-08